Bioprocess Data Management

일시 : 2019.01.14~15

장소 : San Diego, CA, United States of America

주최: Cambridge Healthtech Institute

The biopharmaceutical industry is meeting increasing demands and costs for biotherapeutics through process optimization. Advanced instrumentation through sampling techniques, new sensor technologies, and analyzers have emerged to monitor both upstream and downstream processes. When well-prepared and analyzed, this data leads to process knowledge, process control, and continuous improvement resulting in greater speed, quality, and economy.  

Cambridge Healthtech Institute’s 3rd Annual Bioprocess Data Management conference addresses statistical analysis strategies including multivariate data analysis (MVDA), quality by design (QbD), process analytical technology (PAT), and multi-attribute method (MAM), allowing for optimized and informed control of bioprocessing.

2019 PIPELINES & AGENDAS

January 14-15
Recombinant Protein Therapeutics

January 15-16
Computational and Analytical Tools for Protein Engineering

January 17-18
Deep Sequencing and Single Cell Analysis for Antibody Discovery

January 14-15
Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier

January 15-16
Next-Generation Approaches to Antibody Screening and Discovery

January 17-18
Deep Sequencing and Single Cell Analysis for Antibody Discovery

January 14-15
Engineering Next-Generation Cancer Immunotherapies

January 15-16
Antibody-Drug Conjugates

January 17-18
Bispecific Antibody Therapeutics

January 14-15
Optimizing Biologics Formulation Development

January 15-16
Lyophilization and Emerging Drying Technologies

January 17-18
Protein Aggregation and Emerging Analytical Tools

January 14-15
Characterization of Biotherapeutics

January 15-16
Detection and Characterization of Particulates and Impurities

January 17-18
Protein Aggregation and Emerging Analytical Tools

January 14-15
Bioprocess Data Management

January 15-16
Protein Purification and Recovery

January 17-18
Higher-Throughput Protein Production and Characterization

January 14-15
Engineering Genes, Vectors, Constructs, and Clones

January 15-16
Recombinant Protein Expression and Production

January 16-17
CHO Cell Lines

January 17-18
Optimizing Expression Platforms

January 14-15
Engineering Genes, Vectors, Constructs, and Clones

January 15-16
Advances in Vector Production and Scale-Up for Cell and Gene Therapy

January 17-18
Microbial Production

...................(계속)

☞ 자세한 내용은 내용바로가기 또는 첨부파일을 이용하시기 바랍니다.